MindWalk Holdings Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
24.4%projected annual EPS growth
Analyst Coverage
3analysts covering
FY EPS (est.)
-$0.14next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Growth (YoY) Quarterly52.0%Target: Continued double-digit growth driven by LensAI platform adoption
Gross Margin Quarterly59.0%Target: Margin expansion as LensAI platform adoption increases
U.S. Market Revenue Quarterly2.6MTarget: Further commercial expansion in North America
Watch Items
- Dengue Pipeline Program ProgressTrigger: Completion of pan-neutralization testing with independent third-party collaboratorAction: Evaluate transition of candidate to clinical development or strategic partnership
- SaaS Model Transition and LensAI Enterprise ContractsTrigger: Signing of additional annual enterprise LensAI platform contractsAction: Monitor monthly recurring revenue (MRR) metrics and SaaS contract pipeline
Research as of 19 Jun 2026